112 related articles for article (PubMed ID: 1849657)
41. Analysis of SCG10 gene expression in transgenic mice reveals that neural specificity is achieved through selective derepression.
Wuenschell CW; Mori N; Anderson DJ
Neuron; 1990 Apr; 4(4):595-602. PubMed ID: 2322463
[TBL] [Abstract][Full Text] [Related]
42. Enhancers and transcription factors in the control of gene expression.
Wasylyk B
Biochim Biophys Acta; 1988 Nov; 951(1):17-35. PubMed ID: 2847797
[No Abstract] [Full Text] [Related]
43. Molecular analysis of synapsin I, a candidate gene for Rett syndrome.
DeGennaro LJ; McCaffery CA; Kirchgessner CU; Yang-Feng TL; Francke U
Brain Dev; 1987; 9(5):469-74. PubMed ID: 3124657
[TBL] [Abstract][Full Text] [Related]
44. Genes for synapsin I, a neuronal phosphoprotein, map to conserved regions of human and murine X chromosomes.
Yang-Feng TL; DeGennaro LJ; Francke U
Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8679-83. PubMed ID: 3095840
[TBL] [Abstract][Full Text] [Related]
45. An analysis of synapsin II, a neuronal phosphoprotein, in postmortem brain tissue from alcoholic and neuropsychiatrically ill adults and medically ill children and young adults.
Grebb JA; Greengard P
Arch Gen Psychiatry; 1990 Dec; 47(12):1149-56. PubMed ID: 2147098
[TBL] [Abstract][Full Text] [Related]
46. Mutation analysis of synapsin III gene in schizophrenia.
Tsai MT; Hung CC; Tsai CY; Liu MY; Su YC; Chen YH; Hsiao KJ; Chen CH
Am J Med Genet; 2002 Jan; 114(1):79-83. PubMed ID: 11840510
[TBL] [Abstract][Full Text] [Related]
47. Regulatory Architecture of the Neuronal Cacng2/Tarpγ2 Gene Promoter: Multiple Repressive Domains, a Polymorphic Regulatory Short Tandem Repeat, and Bidirectional Organization with Co-regulated lncRNAs.
Corney BPA; Widnall CL; Rees DJ; Davies JS; Crunelli V; Carter DA
J Mol Neurosci; 2019 Feb; 67(2):282-294. PubMed ID: 30478755
[TBL] [Abstract][Full Text] [Related]
48. New light on synapsin I.
Rodnight R
Nature; 1985 May 30-Jun 5; 315(6018):371-2. PubMed ID: 3923364
[No Abstract] [Full Text] [Related]
49. A gene regulatory system that directs gene expression at the 32-cell stage.
Tokuoka M
Genesis; 2023 Nov; 61(6):e23545. PubMed ID: 37641459
[No Abstract] [Full Text] [Related]
50. Corrigendum: Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B.
Jackson KL; Dayton RD; Deverman BE; Klein RL
Front Mol Neurosci; 2016; 9():154. PubMed ID: 28008310
[TBL] [Abstract][Full Text] [Related]
51. Distinct phosphorylation states of mammalian CaMKIIβ control the induction and maintenance of sleep.
Tone D; Ode KL; Zhang Q; Fujishima H; Yamada RG; Nagashima Y; Matsumoto K; Wen Z; Yoshida SY; Mitani TT; Arisato Y; Ohno RI; Ukai-Tadenuma M; Yoshida Garçon J; Kaneko M; Shi S; Ukai H; Miyamichi K; Okada T; Sumiyama K; Kiyonari H; Ueda HR
PLoS Biol; 2022 Oct; 20(10):e3001813. PubMed ID: 36194579
[TBL] [Abstract][Full Text] [Related]
52. AAV-p40 Bioengineering Platform for Variant Selection Based on Transgene Expression.
Westhaus A; Cabanes-Creus M; Jonker T; Sallard E; Navarro RG; Zhu E; Baltazar Torres G; Lee S; Wilmott P; Gonzalez-Cordero A; Santilli G; Thrasher AJ; Alexander IE; Lisowski L
Hum Gene Ther; 2022 Jun; 33(11-12):664-682. PubMed ID: 35297686
[TBL] [Abstract][Full Text] [Related]
53. Cell-type-specific effects of genetic variation on chromatin accessibility during human neuronal differentiation.
Liang D; Elwell AL; Aygün N; Krupa O; Wolter JM; Kyere FA; Lafferty MJ; Cheek KE; Courtney KP; Yusupova M; Garrett ME; Ashley-Koch A; Crawford GE; Love MI; de la Torre-Ubieta L; Geschwind DH; Stein JL
Nat Neurosci; 2021 Jul; 24(7):941-953. PubMed ID: 34017130
[TBL] [Abstract][Full Text] [Related]
54. CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice.
Schmid RS; Deng X; Panikker P; Msackyi M; Breton C; Wilson JM
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33411694
[TBL] [Abstract][Full Text] [Related]
55. Optimization of adeno-associated viral vector-mediated transduction of the corticospinal tract: comparison of four promoters.
Nieuwenhuis B; Haenzi B; Hilton S; Carnicer-Lombarte A; Hobo B; Verhaagen J; Fawcett JW
Gene Ther; 2021 Feb; 28(1-2):56-74. PubMed ID: 32576975
[TBL] [Abstract][Full Text] [Related]
56. Functional imaging of neuron-astrocyte interactions in a compartmentalized microfluidic device.
Gao Y; Broussard J; Haque A; Revzin A; Lin T
Microsyst Nanoeng; 2016; 2():15045. PubMed ID: 31057811
[TBL] [Abstract][Full Text] [Related]
57. Cell Surface Antigen Display for Neuronal Differentiation-Specific Tracking.
Kim SC; Lee EH; Yu JH; Kim SM; Nam BG; Chung HY; Kim YS; Cho SR; Park CH
Biomol Ther (Seoul); 2019 Jan; 27(1):78-84. PubMed ID: 30458601
[TBL] [Abstract][Full Text] [Related]
58. Synapsins regulate brain-derived neurotrophic factor-mediated synaptic potentiation and axon elongation by acting on membrane rafts.
Kao HT; Ryoo K; Lin A; Janoschka SR; Augustine GJ; Porton B
Eur J Neurosci; 2017 Apr; 45(8):1085-1101. PubMed ID: 28245069
[TBL] [Abstract][Full Text] [Related]
59. Gene therapy approaches in the non-human primate model of Parkinson's disease.
Pignataro D; Sucunza D; Rico AJ; Dopeso-Reyes IG; Roda E; Rodríguez-Perez AI; Labandeira-Garcia JL; Broccoli V; Kato S; Kobayashi K; Lanciego JL
J Neural Transm (Vienna); 2018 Mar; 125(3):575-589. PubMed ID: 28130586
[TBL] [Abstract][Full Text] [Related]
60. SMN expression is required in motor neurons to rescue electrophysiological deficits in the SMNΔ7 mouse model of SMA.
McGovern VL; Iyer CC; Arnold WD; Gombash SE; Zaworski PG; Blatnik AJ; Foust KD; Burghes AH
Hum Mol Genet; 2015 Oct; 24(19):5524-41. PubMed ID: 26206889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
